Log in
Show password
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 


SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Mannatech Incorporated : Announces Preliminary Results of Tender Offer

06/28/2021 | 05:41pm EDT

Mannatech, Incorporated ("Mannatech" or the "Company") (NASDAQ: MTEX), a global health and wellness company committed to transforming lives to make a better world, announced today the preliminary results of its cash tender offer, which expired at 12:00 midnight, New York City time, at the end of Friday, June 25, 2021, to purchase up to 211,538 shares of its outstanding common stock, par value $0.0001 per share, at a per share price of $26.00 (the "tender offer").

Based on the preliminary count by Computershare Trust Company, N.A., the depositary for the tender offer (the "Depositary"), a total of 169,622 shares of common stock of the Company were properly tendered and not properly withdrawn, excluding 4,627 shares that were tendered by notice of guaranteed delivery.

In accordance with the terms and conditions of the tender offer and based on a preliminary count by the Depositary, the Company expects to accept for payment a total of 174,249 shares of common stock of the Company at a cash purchase price of $26.00 per share, for a total cash cost of approximately $4,530,474, excluding fees and expenses relating to the tender offer. Such shares of common stock represented approximately 8.45% of the Company's total outstanding shares as of April 30, 2021.

The Company anticipates to fund the share purchase in the tender offer from cash on hand.

The number of shares expected to be purchased in the tender offer and the aggregate cash purchase price are preliminary and subject to change and are based on the assumption that all shares tendered through notice of guaranteed delivery will be delivered within the two trading day settlement period. The final number of shares to be purchased in the tender offer and the final aggregate cash purchase price will be announced following the expiration of the guaranteed delivery period and the completion of the confirmation process by the Depositary. Payment for the shares accepted for purchase pursuant to the tender offer will occur promptly thereafter.

The Company's tender offer was made pursuant to an Offer to Purchase and Letter of Transmittal, each dated May 28, 2021.

About Mannatech

Mannatech, Incorporated is committed to transforming lives through the development of high quality integrated health, weight management, fitness and skin care products distributed through its global network of independent associates and members. The company has been operating for more than 25 years with operations in 25 markets^. For more information, visit Mannatech.com.

^ Mannatech operates in China under a cross-border e-commerce platform that is separate from its network marketing model.

Please Note: This release contains “forward-looking statements.” These forward-looking statements generally can be identified by use of phrases or terminology such as “may,” “will,” “should,” "hope," “could,” “would,” “expects,” “plans,” “intends,” “anticipates,” “believes,” “estimates,” “approximates,” “predicts,” “projects,” “potential,” “preliminary,” and “continues” or other similar words or the negative of such terminology. Similarly, descriptions of Mannatech’s objectives, strategies, plans, goals or targets contained herein are also considered forward-looking statements. Mannatech believes this release should be read in conjunction with all of its filings with the United States Securities and Exchange Commission (the “SEC”) and cautions its readers that these forward-looking statements are subject to certain events, risks, uncertainties, and other factors. Some of these factors include, among others, Mannatech’s ability to complete the tender offer in a timely manner or at all, the price at which shares of Mannatech's common stock may trade on Nasdaq, which may be higher or lower than the purchase price in the tender offer, uncertainty as to the number of shares purchased in the tender offer, the impact of the outbreak of the novel coronavirus ("COVID-19") pandemic, Mannatech's inability to attract and retain associates and preferred customers, increases in competition, litigation, regulatory changes, and its planned growth into new international markets. Although Mannatech believes that the expectations, statements, and assumptions reflected in these forward-looking statements are reasonable, it cautions readers to always consider all of the risk factors and any other cautionary statements carefully in evaluating each forward-looking statement in this release, as well as those set forth in its latest Annual Report on Form 10-K and Quarterly Report on Form 10-Q, and other filings filed with the SEC, including its current reports on Form 8-K. All of the forward-looking statements contained herein speak only as of the date of this release.

ę Business Wire 2021
09/21MANNATECH INCORPORATED : Board Authorizes Buyback Plan of Up to $1 Million Common Shares
09/21MANNATECH INCORPORATED : Announces Share Repurchase Program (Form 8-K)
09/21Mannatech, Incorporated announces an Equity Buyback for $1 million worth of its shares.
09/21MANNATECH INC : Other Events (form 8-K)
09/21MANNATECH INCORPORATED : Announces Share Repurchase Program
09/21Mannatech, Incorporated authorizes a Buyback Plan.
09/14MANNATECH, INCORPORATED : Ex-dividend day for
08/31MANNATECH INCORPORATED : Lifts Cash Dividend to $0.20/Share From $0.16/Share, Payable Sept..
08/31MANNATECH INCORPORATED : Declares Second Quarter 2021 Dividend
08/31MANNATECH INCORPORATED : Declares Second Quarter 2021 Dividend (Form 8-K)
More news
Financials (USD)
Sales 2020 151 M - -
Net income 2020 6,26 M - -
Net cash 2020 13,3 M - -
P/E ratio 2020 6,71x
Yield 2020 3,25%
Capitalization 65,4 M 65,4 M -
EV / Sales 2019 0,14x
EV / Sales 2020 0,17x
Nbr of Employees 226
Free-Float 32,0%
Duration : Period :
Mannatech, Incorporated Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MANNATECH, INCORPORATED
Short TermMid-TermLong Term
Income Statement Evolution
Managers and Directors
Alfredo Bala President & Chief Executive Officer
David A. Johnson Chief Financial Officer
J. Stanley Fredrick Chairman
Larry A. Jobe Independent Director
Robert A. Toth Vice Chairman
Sector and Competitors
1st jan.Capi. (M$)
BY-HEALTH CO., LTD.5.96%6 733
MEDIFAST, INC.9.15%2 433